Related Experiment Videos
[Juvenile dermatomyositis].
L Tambić-Bukovac1, I Malcić, A Prohić
1Klinika za pedijatriju, Zavod za djecju kardiologiju i reumatologiju, Klinicki bolnicki centar Zagreb.
Reumatizam
|December 13, 2002
Summary
Juvenile dermatomyositis (JDM) in Croatia shows varied outcomes, with many children achieving remission or cure through modern therapies. This study highlights JDM epidemiology and treatment approaches in Croatian pediatric patients.
Area of Science:
- Pediatrics
- Rheumatology
- Epidemiology
Context:
- Juvenile dermatomyositis (JDM) is a rare autoimmune disease affecting children.
- Limited epidemiological data on JDM exists for Croatia.
- The KBC Zagreb Department of Pediatrics manages severe JDM cases.
Purpose:
- To present probable epidemiological characteristics of JDM in Croatian children.
- To review current diagnostic and therapeutic guidelines for JDM.
- To analyze treatment outcomes and prognosis for JDM patients.
Summary:
- The study analyzed 18 pediatric JDM cases from 1988-1999 in Croatia.
- Male predominance (2.6:1) was observed, with a mean age of 10 years at diagnosis.
- Outcomes included 28% cured, 39% in remission, 16% mortality, and complications like calcinosis and overlap syndromes.
Impact:
- Provides crucial epidemiological data for JDM in Croatia.
- Informs diagnostic and therapeutic strategies for pediatric rheumatologists.
- Highlights the improved prognosis of JDM with current treatments compared to historical views.